BenevolentAI
ben is progressing in an adaptive phase i clinical study with full data expected in mid part a part first in human dose cohorts completed data expected late mild moderate patients years per cohort ben placebo safety tolerability adaptive ascending dose cohort design imaging evaluate human skin includes review late part a variability and response statistical modelling part design cohort full data expected by middle of mild moderate patients years per arm design and sample size dependent on part a outcome outcome measures include itch and in viga additional safety tolerability and panel mechanism and effect our intention is to out development and of ben following completion of this trial with good interest from key big and dermatology specialists as potential partners | BenevolentAI
Company
Deck Type
Sector
Industry
Deck date
December 2021
Slide
24 of 42
Similar slides by BenevolentAI
See diffirences between slides (animation)
Investor Presentation
June 2022
ben is progressing in an adaptive phase i clinical study with full data expected end of | BenevolentAI
Related slides by other companies
Aeglea BioTherapeutics
Investor Day
October 2022
| Aeglea BioTherapeutics
Exscientia
Investor Presentation
November 2023
elucidate phase ongoing in advanced solid | Exscientia
Aeglea BioTherapeutics
Mergers and Acquisitions
June 2023
is building a potentially best in class pipeline with next generation and rational combinations | Aeglea BioTherapeutics
Exscientia
Investor Day
January 2024
elucidate phase ongoing in advanced solid | Exscientia
Other recent decks by BenevolentAI
See all presentations (10 decks)
Results
March 2024
Investor Conference
January 2024
Investor Presentation
May 2023
Results
March 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io